Skip to main content
Top
Published in: Breast Cancer Research 2/2005

01-06-2005 | Poster Presentation

Molecular characterization of breast cell lines: a tool for breast cancer studies

Authors: E Charafe-Jauffret, C Ginestier, F Monville, J Adélaïde, P Finetti, F Bertucci, L Xerri, J Jacquemier, D Birnbaum

Published in: Breast Cancer Research | Special Issue 2/2005

Login to get access

Excerpt

Breast cancer is a complex, heterogeneous disease at the molecular level. Recent advances proposed a new molecular taxonomy of breast cancer that defines molecular subtypes such as luminal or basal-like cancers. Hopefully this may modify breast cancer management. A great part of our knowledge on breast carcinomas is based on studies of breast cancer cell lines (BCC). Although many data are available on BCC lines, less is actually known on their molecular characterization. We have determined the molecular subtype of 31 BCC using DNA microarrays and confirmed their phenotype by immunohistochemistry (IHC) on 'cell microarrays' (CMA). …
Metadata
Title
Molecular characterization of breast cell lines: a tool for breast cancer studies
Authors
E Charafe-Jauffret
C Ginestier
F Monville
J Adélaïde
P Finetti
F Bertucci
L Xerri
J Jacquemier
D Birnbaum
Publication date
01-06-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1154

Other articles of this Special Issue 2/2005

Breast Cancer Research 2/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine